Abigail L Kehrer-Dunlap, Audrey A Keleman, Rebecca M Bollinger, Susan L Stark
{"title":"Falls and Alzheimer Disease.","authors":"Abigail L Kehrer-Dunlap, Audrey A Keleman, Rebecca M Bollinger, Susan L Stark","doi":"10.20900/agmr.20240001","DOIUrl":null,"url":null,"abstract":"<p><p>Falls are the leading cause of injury, disability, and injury-related mortality in the older adult population. Older adults with Alzheimer disease (AD) are over twice as likely to experience a fall compared to cognitively normal older adults. Intrinsic and extrinsic fall risk factors may influence falls during symptomatic AD; intrinsic factors include changes in cognition and impaired functional mobility, and extrinsic factors include polypharmacy and environmental fall hazards. Despite many known fall risk factors, the high prevalence of falls, and the presence of effective fall prevention interventions for older adults without cognitive impairment, effective fall prevention interventions for older adults with AD to date are limited and inconclusive. Falls may precede AD-related cognitive impairment during the preclinical phase of AD, though a narrow understanding of fall risk factors and fall prevention interventions for older adults with preclinical AD limits clinical treatment of falls among cognitively normal older adults with preclinical AD. This mini review explores fall risk factors in symptomatic AD, evidence for effective fall prevention interventions in symptomatic AD, and preclinical AD as an avenue for future falls research, including recommendations for future research directions to improve our understanding of falls and fall risk during preclinical AD. Early detection and tailored interventions to address these functional changes are needed to reduce the risk of falls for those at risk for developing AD. Concerted efforts should be dedicated to understanding falls to inform precision fall prevention strategies for this population.</p>","PeriodicalId":72094,"journal":{"name":"Advances in geriatric medicine and research","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10977097/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in geriatric medicine and research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20900/agmr.20240001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/14 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Falls are the leading cause of injury, disability, and injury-related mortality in the older adult population. Older adults with Alzheimer disease (AD) are over twice as likely to experience a fall compared to cognitively normal older adults. Intrinsic and extrinsic fall risk factors may influence falls during symptomatic AD; intrinsic factors include changes in cognition and impaired functional mobility, and extrinsic factors include polypharmacy and environmental fall hazards. Despite many known fall risk factors, the high prevalence of falls, and the presence of effective fall prevention interventions for older adults without cognitive impairment, effective fall prevention interventions for older adults with AD to date are limited and inconclusive. Falls may precede AD-related cognitive impairment during the preclinical phase of AD, though a narrow understanding of fall risk factors and fall prevention interventions for older adults with preclinical AD limits clinical treatment of falls among cognitively normal older adults with preclinical AD. This mini review explores fall risk factors in symptomatic AD, evidence for effective fall prevention interventions in symptomatic AD, and preclinical AD as an avenue for future falls research, including recommendations for future research directions to improve our understanding of falls and fall risk during preclinical AD. Early detection and tailored interventions to address these functional changes are needed to reduce the risk of falls for those at risk for developing AD. Concerted efforts should be dedicated to understanding falls to inform precision fall prevention strategies for this population.
跌倒是导致老年人受伤、残疾和因伤死亡的主要原因。与认知能力正常的老年人相比,患有阿尔茨海默病(AD)的老年人发生跌倒的几率是后者的两倍多。内在和外在的跌倒风险因素可能会影响有症状的老年痴呆症患者的跌倒;内在因素包括认知的变化和功能性活动能力受损,外在因素包括多药治疗和环境中的跌倒危险。尽管存在许多已知的跌倒风险因素,跌倒的发生率也很高,而且针对无认知障碍的老年人采取了有效的跌倒预防干预措施,但迄今为止针对患有注意力缺失症的老年人采取的有效跌倒预防干预措施却很有限,且尚无定论。在 AD 的临床前期阶段,跌倒可能先于 AD 相关的认知障碍发生,但对临床前期 AD 老年人跌倒风险因素和跌倒预防干预措施的狭隘理解限制了对认知正常的临床前期 AD 老年人跌倒的临床治疗。这篇微型综述探讨了有症状 AD 中的跌倒风险因素、有症状 AD 中有效预防跌倒干预措施的证据以及作为未来跌倒研究途径的临床前 AD,包括对未来研究方向的建议,以提高我们对临床前 AD 中跌倒和跌倒风险的认识。我们需要及早发现并采取有针对性的干预措施来应对这些功能性变化,以降低有可能发展为注意力缺失症的人群跌倒的风险。我们应齐心协力了解跌倒,为这一人群制定精准的跌倒预防策略提供依据。